Rapid COVID-19 vaccine rollout: immense success but challenges ahead

Frank G. Sandmann; Mark Jit

doi:10.1016/S1473-3099(21)00616-2

Rapid COVID-19 vaccine rollout: immense success but challenges ahead

Frank G. Sandmann, Mark Jit

Global Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	302-304
Number of pages	3
Journal	The Lancet Infectious Diseases
Volume	22
Issue number	3
DOIs	https://doi.org/10.1016/S1473-3099(21)00616-2
State	Published - Mar 2022

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1016/S1473-3099(21)00616-2

Cite this

@article{897a240bc4cc4833ac08620a69275983,

title = "Rapid COVID-19 vaccine rollout: immense success but challenges ahead",

author = "Sandmann, {Frank G.} and Mark Jit",

year = "2022",

month = mar,

doi = "10.1016/S1473-3099(21)00616-2",

language = "English (US)",

volume = "22",

pages = "302--304",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd",

number = "3",

}

TY - JOUR

T1 - Rapid COVID-19 vaccine rollout

T2 - immense success but challenges ahead

AU - Sandmann, Frank G.

AU - Jit, Mark

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85124937163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124937163&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(21)00616-2

DO - 10.1016/S1473-3099(21)00616-2

M3 - Comment/debate

C2 - 34562376

AN - SCOPUS:85124937163

SN - 1473-3099

VL - 22

SP - 302

EP - 304

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 3

ER -

Rapid COVID-19 vaccine rollout: immense success but challenges ahead

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this